PTX 3.70% 3.9¢ prescient therapeutics limited

PTX Media related, page-1119

  1. 401 Posts.
    lightbulb Created with Sketch. 64
    Realistically, what known event is going to cause this stock to re-rate? Based off the market reaction to the PTX100 results, the PTX200 readout will have little, if any, impact on the shareprice. The market knows about the 4 CRs in that study, so if there are no additional responses then nothing will happen here. The commencement of the CAR-T clinical trials won't have any impact since it will just be a phase 1 study. The only thing that could propel this is the FDA grant of registrational study for PTX100. Wouldn't expect to hear anything about this until closer to year-end. We will see 6-7c again pretty soon I imagine.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.002(3.70%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $13.44K 339.6K

Buyers (Bids)

No. Vol. Price($)
8 496584 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 270984 7
View Market Depth
Last trade - 13.28pm 24/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.